BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: LeBlanc JF, Wiseman D, Lakatos PL, Bessissow T. Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape. World J Gastroenterol 2019; 25(30): 4158-4171 [PMID: 31435170 DOI: 10.3748/wjg.v25.i30.4158]
URL: https://www.wjgnet.com/1007-9327/full/v25/i30/4158.htm
Number Citing Articles
1
Fang Xu, Anne G. Wheaton, Kamil E. Barbour, Yong Liu, Kurt J. Greenlund. Trends and Outcomes of Hip Fracture Hospitalization Among Medicare Beneficiaries with Inflammatory Bowel Disease, 2000–2017Digestive Diseases and Sciences 2021; 66(6): 1818 doi: 10.1007/s10620-020-06476-z
2
Brigida Barberio, Christopher J Black, Edoardo V Savarino, Alexander C Ford. Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-AnalysisJournal of Crohn's and Colitis 2021; 15(5): 733 doi: 10.1093/ecco-jcc/jjaa226
3
Nik Sheng Ding, Daniel Tassone, Ibrahim Al Bakir, Kyle Wu, Alexander J Thompson, William R Connell, George Malietzis, Phillip Lung, Siddharth Singh, Chang-ho Ryan Choi, Simon Gabe, John T Jenkins, Ailsa Hart. Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2022;  doi: 10.1093/ecco-jcc/jjac041
4
Tarek Hassab, Duncan McKinney, Christopher D. D'Adamo, Shane Svoboda, Mark Katlic, Joshua H. Wolf. Short-Term Outcomes for Restorative and Non-Restorative Proctocolectomy in Older AdultsJournal of Surgical Research 2022; 269: 11 doi: 10.1016/j.jss.2021.07.012
5
Marco Gentili, Laura Hidalgo‐Garcia, Teresa Vezza, Erika Ricci, Graziella Migliorati, Alba Rodriguez‐Nogales, Carlo Riccardi, Julio Galvez, Simona Ronchetti. A recombinant glucocorticoid‐induced leucine zipper protein ameliorates symptoms of dextran sulfate sodium‐induced colitis by improving intestinal permeabilityThe FASEB Journal 2021; 35(11) doi: 10.1096/fj.202100778RRRR
6
Sophie Vieujean, Bénédicte Caron, Vipul Jairath, Athanase Benetos, Silvio Danese, Edouard Louis, Laurent Peyrin-Biroulet. Is it time to include older adults in inflammatory bowel disease trials? A call for actionThe Lancet Healthy Longevity 2022; 3(5): e356 doi: 10.1016/S2666-7568(22)00060-5
7
C. Thompson, S. Taleban. Incorporating Frailty in the Treatment Program of Elderly Patients with Gastrointestinal DiseaseCurrent Treatment Options in Gastroenterology 2020; 18(4): 635 doi: 10.1007/s11938-020-00310-1
8
Shervin Sharifkashani. Radiopaedia.org2022;  doi: 10.53347/rID-98131
9
Rajat Garg, Manik Aggarwal, Robert Butler, Jean Paul Achkar, Bret Lashner, Jessica Philpott, Benjamin Cohen, Taha Qazi, Florian Rieder, Miguel Regueiro, Benjamin Click. Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn’s Disease PatientsDigestive Diseases and Sciences 2022; 67(7): 3138 doi: 10.1007/s10620-021-07117-9
10
Enrique de-Madaria, José J Mira, Irene Carrillo, Waqqas Afif, Daphne Ang, Marina Antelo, Steven Bollipo, Antoni Castells, Prabhleen Chahal, Henriette Heinrich, Joanna K Law, Monique E van Leerdam, Sabela Lens, Rahul Pannala, San Hyoung Park, Atoosa Rabiee, Edoardo V Savarino, Vikesh K Singh, John Vargo, Aline Charabaty, Joost P H Drenth. The present and future of gastroenterology and hepatology: an international SWOT analysis (the GASTROSWOT project)The Lancet Gastroenterology & Hepatology 2022; 7(5): 485 doi: 10.1016/S2468-1253(21)00442-8
11
Simon J. Hong, Jonathan Galati, Seymour Katz. Crohn's Disease of the ElderlyGastroenterology Clinics of North America 2022; 51(2): 425 doi: 10.1016/j.gtc.2021.12.014
12
Simon J. Hong, Seymour Katz. Inflammatory Bowel DiseaseClinical Gastroenterology 2021; : 283 doi: 10.1007/978-3-030-81780-0_12
13
Simon J. Hong, Seymour Katz. The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic managementTherapeutic Advances in Gastroenterology 2021; 14: 175628482110233 doi: 10.1177/17562848211023399
14
Paula Miksa, Shane Ryan Apperley. Inflammatory Bowel Disease: Managing Complex PatientsPhysician Assistant Clinics 2021; 6(4): 655 doi: 10.1016/j.cpha.2021.05.009
15
Badar Hasan, Kanwarpreet Singh Tandon, Rafael Miret, Sikandar Khan, Amir Riaz, Adalberto Gonzalez, Asad Ur Rahman, Roger Charles, Neeraj Narula, Fernando J. Castro. Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancyJournal of Gastroenterology and Hepatology 2022; 37(6): 1016 doi: 10.1111/jgh.15806